Functional polymorphism of hOGG1 gene is associated with type 2 diabetes mellitus in Chinese population

Molecular and Cellular Endocrinology

Volumn 325, Issue 1-2, 2010, Pages 128-134

  Sun, Caixia ^a,b   Liu, Xiufang ^a,b   Zhang, Huan ^a,b   Guo, Wenwen ^a,b   Cai, Zhenming ^a,b   Chen, Huimei ^a,b   Zhang, Kui ^b   Zhu, Dalong ^b   Wang, Yaping ^a,b  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^b NANJING UNIVERSITY   (China)

Author keywords

8 OHdG; HOGG1 gene; Polymorphism; Promoter activity; Type 2 diabetes mellitus

Indexed keywords

8 OXOGUANINE GLYCOSYLASE 1; C PEPTIDE; GENOMIC DNA; GLYCOSYLTRANSFERASE; UNCLASSIFIED DRUG;

5' UNTRANSLATED REGION; ADULT; ALLELE; ARTICLE; CASE CONTROL STUDY; CELL STRAIN HEK293; CHINESE; CONTROLLED STUDY; DNA SEQUENCE; EXON; FEMALE; GENE MUTATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SCREENING; HELA CELL; HETEROZYGOSITY; HETEROZYGOTE; HOMOZYGOSITY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BASE SEQUENCE; CASE-CONTROL STUDIES; CELLS, CULTURED; DIABETES MELLITUS, TYPE 2; DNA GLYCOSYLASES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENETICS, POPULATION; GENOME-WIDE ASSOCIATION STUDY; HELA CELLS; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC;

EID: 77954382538     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2010.05.005     Document Type: Article

References (43)

1. Arai K., Morishita K., Shinmura K., Kohno T., Kim S.R., Nohmi T., Taniwaki M., Ohwada S., Yokota J. Cloning of a human homolog of the yeast OGG1 gene that is involved in the repair of oxidative DNA damage. Oncogene 1997, 14:2857-2861.
2. Bashirullah A., Cooperstock R.L., Lipshitz H.D. Spatial and temporal control of RNA stability. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:7025-7028.
3. Chappell S.A., LeQuesne J.P., Paulin F.E., deSchoolmeester M.L., Stoneley M., Soutar R.L., Ralston S.H., Helfrich M.H., Willis A.E. A mutation in the c-myc-IRES leads to enhanced internal ribosome entry in multiple myeloma: a novel mechanism of oncogene de-regulation. Oncogene 2000, 19:4437-4440.
4. Chou L.S., Lyon E., Wittwer C.T. A comparison of high-resolution melting analysis with denaturing high-performance liquid chromatography for mutation scanning: cystic fibrosis transmembrane conductance regulator gene as a model. Am. J. Clin. Pathol. 2005, 124:330-338.
5. Conne B., Stutz A., Vassalli J.D. The 3' untranslated region of messenger RNA: a molecular 'hotspot' for pathology?. Nat. Med. 2000, 6:637-641.
6. Daimon M., Oizumi T., Toriyama S., Karasawa S., Jimbu Y., Wada K., Kameda W., Susa S., Muramatsu M., Kubota I., Kawata S., Kato T. Association of the Ser326Cys polymorphism in the OGG1 gene with type 2 DM. Biochem. Biophys. Res. Commun. 2009, 386:26-29.
7. Dandona P., Thusu K., Cook S., Snyder B., Makowski J., Armstrong D., Nicotera T. Oxidative damage to DNA in diabetes mellitus. Lancet 1996, 347:444-445.
8. Evans J.L., Goldfine I.D., Maddux B.A., Grodsky G.M. Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocr. Rev. 2002, 23:599-622.
9. Evans J.L., Goldfine I.D., Maddux B.A., Grodsky G.M. Are oxidative stress-activated signaling pathways mediators of insulin resistance and beta-cell dysfunction?. Diabetes 2003, 52:1-8.
10. Frosina G. Commentary: DNA base excision repair defects in human pathologies. Free Radic. Res. 2004, 38:1037-1054.
11. Garcia-Closas M., Malats N., Real F.X., Welch R., Kogevinas M., Chatterjee N., Pfeiffer R., Silverman D., Dosemeci M., Tardon A., Serra C., Carrato A., Garcia-Closas R., Castano-Vinyals G., Chanock S., Yeager M., Rothman N. Genetic variation in the nucleotide excision repair pathway and bladder cancer risk. Cancer Epidemiol. Biomarkers Prev. 2006, 15:536-542.
12. Goldstein B.J., Mahadev K., Wu X., Zhu L., Motoshima H. Role of insulin-induced reactive oxygen species in the insulin signaling pathway. Antioxid. Redox Signal. 2005, 7:1021-1031.
13. Goode E.L., Ulrich C.M., Potter J.D. Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol. Biomarkers Prev. 2002, 11:1513-1530.
14. Helbock H.J., Beckman K.B., Ames B.N. 8-Hydroxydeoxyguanosine and 8-hydroxyguanine as biomarkers of oxidative DNA damage. Methods Enzymol. 1999, 300:156-166.
15. Hoeijmakers J.H. Genome maintenance mechanisms for preventing cancer. Nature 2001, 411:366-374.
16. Ishida T., Takashima R., Fukayama M., Hamada C., Hippo Y., Fujii T., Moriyama S., Matsuba C., Nakahori Y., Morita H., Yazaki Y., Kodama T., Nishimura S., Aburatani H. New DNA polymorphisms of human MMH/OGG1 gene: prevalence of one polymorphism among lung-adenocarcinoma patients in Japanese. Int. J. Cancer 1999, 80:18-21.
17. Jansen R.P. mRNA localization: message on the move. Nat. Rev. Mol. Cell Biol. 2001, 2:247-256.
18. Kim J.C., Ka I.H., Lee Y.M., Koo K.H., Kim H.C., Yu C.S., Jang S.J., Kim Y.S., Lee H.I., Lee K.H. MYH, OGG1, MTH1, and APC alterations involved in the colorectal tumorigenesis of Korean patients with multiple adenomas. Virchows Arch. 2007, 450:311-319.
19. Kohno T., Shinmura K., Tosaka M., Tani M., Kim S.R., Sugimura H., Nohmi T., Kasai H., Yokota J. Genetic polymorphisms and alternative splicing of the hOGG1 gene, that is involved in the repair of 8-hydroxyguanine in damaged DNA. Oncogene 1998, 16:3219-3225.
20. Lee M.R., Kim S.H., Cho H.J., Lee K.Y., Moon A.R., Jeong H.G., Lee J.S., Hyun J.W., Chung M.H., You H.J. Transcription factors NF-YA regulate the induction of human OGG1 following DNA-alkylating agent methylmethane sulfonate (MMS) treatment. J. Biol. Chem. 2004, 279:9857-9866.
21. Leinonen J., Lehtimaki T., Toyokuni S., Okada K., Tanaka T., Hiai H., Ochi H., Laippala P., Rantalaiho V., Wirta O., Pasternack A., Alho H. New biomarker evidence of oxidative DNA damage in patients with non-insulin-dependent diabetes mellitus. FEBS Lett. 1997, 417:150-152.
22. Nakabeppu Y. Regulation of intracellular localization of human MTH1, OGG1, and MYH proteins for repair of oxidative DNA damage. Prog. Nucleic Acid Res. Mol. Biol. 2001, 68:75-94.
23. Niedernhofer L.J., Garinis G.A., Raams A., Lalai A.S., Robinson A.R., Appeldoorn E., Odijk H., Oostendorp R., Ahmad A., van Leeuwen W., Theil A.F., Vermeulen W., van der Horst G.T., Meinecke P., Kleijer W.J., Vijg J., Jaspers N.G., Hoeijmakers J.H. A new progeroid syndrome reveals that genotoxic stress suppresses the somatotroph axis. Nature 2006, 444:1038-1043.
24. Okasaka T., Matsuo K., Suzuki T., Ito H., Hosono S., Kawase T., Watanabe M., Yatabe Y., Hida T., Mitsudomi T., Tanaka H., Yokoi K., Tajima K. hOGG1 Ser326Cys polymorphism and risk of lung cancer by histological type. J. Hum. Genet. 2009, 54:739-745.
25. Organization W.H. Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications 1999, Department of Noncommunicable Disease Surveillance, WHO, Geneva, Switzerland. Geneva, S.D.o.N.D.S., WHO (Ed.).
26. Paulin F.E., Chappell S.A., Willis A.E. A single nucleotide change in the c-myc internal ribosome entry segment leads to enhanced binding of a group of protein factors. Nucleic Acids Res. 1998, 26:3097-3103.
27. Paz-Elizur T., Krupsky M., Blumenstein S., Elinger D., Schechtman E., Livneh Z. DNA repair activity for oxidative damage and risk of lung cancer. J. Natl. Cancer Inst. 2003, 95:1312-1319.
28. Rachek L.I., Thornley N.P., Grishko V.I., LeDoux S.P., Wilson G.L. Protection of INS-1 cells from free fatty acid-induced apoptosis by targeting hOGG1 to mitochondria. Diabetes 2006, 55:1022-1028.
29. Radicella J.P., Dherin C., Desmaze C., Fox M.S., Boiteux S. Cloning and characterization of hOGG1, a human homolog of the OGG1 gene of Saccharomyces cerevisiae. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:8010-8015.
30. Sakuraba H., Mizukami H., Yagihashi N., Wada R., Hanyu C., Yagihashi S. Reduced beta-cell mass and expression of oxidative stress-related DNA damage in the islet of Japanese Type II diabetic patients. Diabetologia 2002, 45:85-96.
31. Seghrouchni I., Drai J., Bannier E., Riviere J., Calmard P., Garcia I., Orgiazzi J., Revol A. Oxidative stress parameters in type I, type II and insulin-treated type 2 diabetes mellitus; insulin treatment efficiency. Clin. Chim. Acta 2002, 321:89-96.
32. Shinmura K., Yokota J. The OGG1 gene encodes a repair enzyme for oxidatively damaged DNA and is involved in human carcinogenesis. Antioxid. Redox Signal. 2001, 3:597-609.
33. Singh R., Barden A., Mori T., Beilin L. Advanced glycation end-products: a review. Diabetologia 2001, 44:129-146.
34. Sun C., Chen H., Guo W., Zhang K., Qi Q., Gu X., Zhu D., Wang Y. A common mutation of the MYH gene is associated with increased DNA oxidation and age-related diseases. Free Radic. Biol. Med. 2010, 48:430-436.
35. Toyokuni S. Reactive oxygen species-induced molecular damage and its application in pathology. Pathol. Int. 1999, 49:91-102.
36. Toyokuni S., Tanaka T., Hattori Y., Nishiyama Y., Yoshida A., Uchida K., Hiai H., Ochi H., Osawa T. Quantitative immunohistochemical determination of 8-hydroxy-2'-deoxyguanosine by a monoclonal antibody N45.1: its application to ferric nitrilotriacetate-induced renal carcinogenesis model. Lab. Invest. 1997, 76:365-374.
37. Tyrberg B., Anachkov K.A., Dib S.A., Wang-Rodriguez J., Yoon K.H., Levine F. Islet expression of the DNA repair enzyme 8-oxoguanosine DNA glycosylase (Ogg1) in human type 2 diabetes. BMC Endocr. Disord. 2002, 2:2.
38. van der Velden A.W., Thomas A.A. The role of the 5' untranslated region of an mRNA in translation regulation during development. Int. J. Biochem. Cell Biol. 1999, 31:87-106.
39. Wang C.L., Hsieh M.C., Hsin S.C., Lin H.Y., Lin K.D., Lo C.S., Chen Z.H., Shin S.J. The hOGG1 Ser326Cys gene polymorphism is associated with decreased insulin sensitivity in subjects with normal glucose tolerance. J. Hum. Genet. 2006, 51:124-128.
40. Weiss J.M., Goode E.L., Ladiges W.C., Ulrich C.M. Polymorphic variation in hOGG1 and risk of cancer: a review of the functional and epidemiologic literature. Mol. Carcinog. 2005, 42:127-141.
41. Youn C.K., Kim S.H., Lee D.Y., Song S.H., Chang I.Y., Hyun J.W., Chung M.H., You H.J. Cadmium down-regulates human OGG1 through suppression of Sp1 activity. J. Biol. Chem. 2005, 280:25185-25195.
42. Zhang Y., Newcomb P.A., Egan K.M., Titus-Ernstoff L., Chanock S., Welch R., Brinton L.A., Lissowska J., Bardin-Mikolajczak A., Peplonska B., Szeszenia-Dabrowska N., Zatonski W., Garcia-Closas M. Genetic polymorphisms in base-excision repair pathway genes and risk of breast cancer. Cancer Epidemiol. Biomarkers Prev. 2006, 15:353-358.
43. Zhou B.F. Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults-study on optimal cut-off points of body mass index and waist circumference in Chinese adults. Biomed. Environ. Sci. 2002, 15:83-96.